I read with great interest the paper by Au et al 1 published recently in BMT. I have also studied autoimmune dysfunction, particularly hyperthyroidism, in patients with leukemia and lymphoma. 2 In contrast to the series by Au, in all our cases but one, the hyperthyroidism either preceded or accompanied the lymphoproliferative disorders and thus, was not associated with the treatment. We attributed this association to the high incidence of autoimmune phenomena observed with lymphoid neoplasia.
S Paydas
Cukurova University Faculty of Medicine, Medical Oncology, Balcali, Adana, Turkey
